Cell Analysis Market Expected to Reach $42.9 billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Cell Analysis Market," The Cell Analysis Market Size was valued at $17.1 billion in 2022 and is estimated to reach $43 billion by 2032, exhibiting a CAGR of 9.5% from 2023 to 2032.

Cell analysis is a type of laboratory analysis that is used to measure the characteristics of a cell or cell population. It involves the use of various techniques, including cell counting, viability analysis, morphological analysis, and fluorescent microscopy. It can provide information on the size, shape, surface markers, and viability of cells. Furthermore, it can be used to measure the levels of proteins and other molecules within the cell. Cell analysis can be used to detect and diagnose diseases, monitor the response to treatments, and investigate the mechanisms of cellular functions. 

The key Cell Analysis Market Trends are the rise in technological advancement in cell analysis coupled with an increase in R&D activities for cell analysis in the pharmaceutical and biotechnology industry. In addition, an increase in focus on the usage of cell analysis in biomarker discoveries and clinical diagnostics for the diagnosis & treatment of diseases propels the growth Cell Analysis Market Size in upcoming years.

For instance, according to World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, an estimated 17.9 million people die each year from CVDs, which is 31% of all deaths worldwide. However, the high cost of single-cell analysis products is likely to hamper the growth of the cell analysis market during the forecast period. Conversely, the high growth potential of single-cell sequencing is expected to provide numerous opportunities for market growth during the forecast period. 

The Cell Analysis Market Analysis is done on the basis of product, application, technique, end user, and region. By product, the market is bifurcated into consumables, services, software, and instruments. By application, it is segregated into oncology, immunology, cardiology, stem cell, genetic disease, and others.

By technique, the market is categorized into flow cytometry, next-generation sequencing (NGS), polymerase chain reaction (PCR), mass spectrometry, and others. On the basis of end users, it is divided into academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. 

By product, the consumables segment generated the maximum Cell Analysis Market Share in 2022, owing to an increase in the demand for advanced and innovative consumables such as multi-omics assays among research and academic institutes boosts the market's growth.

The services segment is expected to witness the highest CAGR during the forecast period, owing to a surge in focus on stem cell research and wide application of cell analysis, for studying stem cells as the demand for stem cell research has grown, increasing the demand for cell analysis services that drive the growth of the Cell Analysis Market Forecast period.

Depending on the application, the oncology segment generated the maximum cell analysis Market Share in 2022, owing to an increase in the prevalence of cancer across the world drives the growth of the market. The same segment is expected to witness the highest CAGR during the forecast period, owing to a rise in the geriatric population who are more susceptible to cancer worldwide, driving the market's growth.

By technique, the flow cytometry segment generated the maximum cell analysis Market Share in 2022, owing to a rise in technological advancements and an increase in the adoption of flow cytometry technology for cell analysis in various research and diagnostic labs.

The same segment is expected to witness the highest CAGR during the forecast period, owing to a rise in the prevalence of chronic diseases such as cancer, cardiovascular disease, and others across the world driving the market's growth.

On the basis of end user, the Biotechnology and Pharmaceutical Companies segment generated the maximum Cell Analysis Industry Share in 2022, owing to a rise in technological advancement such as the use of microfluidics for the development of next-generation therapies have increased the adoption of cell analysis by biotechnology and pharmaceutical companies.

The same segment is expected to witness the highest CAGR during the forecast period, owing to an increase in the adoption of various key strategies by the market players like product approval, product launch, partnership, and collaboration also propel the growth of the market.

Region-wise, North America has the highest Cell Analysis Industry share, owing to the well-established healthcare system, increase in the number of geriatric patients, presence of key market players, and supportive reimbursement policies in the healthcare system. In addition, increases in R&D expenditure and federal funding further boost market growth. 

Asia-Pacific is projected to register the highest CAGR of 10.5% during the forecast period. The rise in per capita income, the surge in the medical tourism industry, and an upsurge in public awareness regarding the benefits of cell analysis are the key factors that boost the growth of the market in this region. 

Key findings of the study  

• On the basis of product, the consumables segment dominated the market in 2022 and is expected to continue this trend during the forecast period. 

• On the basis of application, the oncology segment dominated the market in 2022 and is expected to continue this trend during the forecast period. 

• On the basis of technique, the flow cytometry segment dominated the market in 2022 and is expected to continue this trend during the forecast period. 

• Depending on the end user, the biotechnology and pharmaceutical companies segment is projected to grow at the highest CAGR during the forecast period. 

• Region-wise, North America garnered the largest revenue share in 2022. However, Europe is anticipated to grow at the highest CAGR during the forecast period.